First City Capital Management, Inc. Eli Lilly & CO Transaction History

First City Capital Management, Inc.

$194 Million
Q3 2024

A detailed history of First City Capital Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, First City Capital Management, Inc. holds 8,367 shares of LLY stock, worth $6.3 Million. This represents 3.83% of its overall portfolio holdings.

Number of Shares

8,367

Previous 8,476 1.29%

Holding current value

$6.3 Million

Previous $7.67 Million 3.41%

% of portfolio

3.83%

Previous 4.38%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$772.14 - $960.02 $84,163 - $104,642	-109 Reduced 1.29%	8,367 $7.41 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $300,096 - $376,342	-414 Reduced 4.66%	8,476 $7.67 Million
Q1 2024 May 22, 2024	SELL	$592.2 - $792.28 $776,966 - $1.04 Million	-1,312 Reduced 12.86%	8,890 $6.92 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $88,231 - $104,013	-168 Reduced 1.62%	10,202 $5.95 Million
Q3 2023 Oct 26, 2023	SELL	$434.7 - $599.3 $752,900 - $1.04 Million	-1,732 Reduced 14.31%	10,370 $5.57 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $283,397 - $378,935	-808 Reduced 6.26%	12,102 $5.68 Million
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $79,521 - $93,393	256 Added 2.02%	12,910 $4.43 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $278,140 - $324,089	-865 Reduced 6.4%	12,654 $4.63 Million
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $76,491 - $87,170	-258 Reduced 1.87%	13,519 $4.37 Million
Q2 2022 Jul 21, 2022	SELL	$278.73 - $327.27 $29,824 - $35,017	-107 Reduced 0.77%	13,777 $4.47 Million
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $48,346 - $60,081	206 Added 1.51%	13,884 $3.98 Million
Q4 2021 Feb 07, 2022	SELL	$224.85 - $279.04 $232,944 - $289,085	-1,036 Reduced 7.04%	13,678 $3.31 Million
Q3 2021 Oct 28, 2021	BUY	$221.6 - $272.71 $10,636 - $13,090	48 Added 0.33%	14,714 $3.4 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $13,721 - $17,749	76 Added 0.52%	14,666 $3.86 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $119,953 - $155,285	-730 Reduced 4.77%	14,590 $2.82 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $1.96 Million - $2.59 Million	-15,018 Reduced 49.5%	15,320 $3.1 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $1.92 Million - $2.22 Million	13,135 Added 76.35%	30,338 $4.49 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $68,755 - $82,746	504 Added 3.02%	17,203 $2.82 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $95,716 - $118,469	-804 Reduced 4.59%	16,699 $2.32 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $13,365 - $16,553	-125 Reduced 0.71%	17,503 $2.3 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $205,997 - $224,072	-1,929 Reduced 9.86%	17,628 $1.97 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $2,215 - $2,586	-20 Reduced 0.1%	19,557 $2.17 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $94,056 - $110,711	-845 Reduced 4.14%	19,577 $2.54 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $99,969 - $111,996	-944 Reduced 4.42%	20,422 $2.36 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $49,369 - $61,703	-575 Reduced 2.62%	21,366 $2.29 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $26,495 - $30,408	-350 Reduced 1.57%	21,941 $1.87 Million
Q4 2017 Feb 12, 2018	SELL	$81.94 - $87.89 $53,261 - $57,128	-650 Reduced 2.83%	22,291 $1.88 Million
Q3 2017 Oct 31, 2017	SELL	$77.07 - $85.54 $34,296 - $38,065	-445 Reduced 1.9%	22,941 $1.96 Million
Q2 2017 Aug 14, 2017	BUY	N/A	23,386	23,386 $1.93 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First City Capital Management, Inc. with notifications on news.

Account

First City Capital Management, Inc. Eli Lilly & CO Transaction History